Where Does Lexicon Pharmaceuticals, Inc. (LXRX) Stock Fall in the Biotechnology Field After It Is Higher By 1.02% This Week?

Lexicon Pharmaceuticals, Inc. (LXRX) is near the top in its industry group according to InvestorsObserver. LXRX gets an overall rating of 57. That means it scores higher than 57 percent of stocks. Lexicon Pharmaceuticals, Inc. gets a 83 rank in the Biotechnology industry. Biotechnology is number 80 out of 148 industries.

LXRX has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on LXRX!

See Full LXRX Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 57 would rank higher than 57 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Lexicon Pharmaceuticals, Inc. Stock Today?

Lexicon Pharmaceuticals, Inc. (LXRX) stock is up 2.27% while the S&P 500 is down -0.87% as of 9:54 AM on Wednesday, Oct 6. LXRX is higher by $0.11 from the previous closing price of $4.85 on volume of 142,427 shares. Over the past year the S&P 500 is higher by 28.17% while LXRX is higher by 244.44%. LXRX earned $0.39 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 12.83. Click Here to get the full Stock Report for Lexicon Pharmaceuticals, Inc. stock.